Trials / Unknown
UnknownNCT03846271
Effects of Oxytocin on Reinforcement Learning
The Effects of Intranasal Oxytocin on Reward Sensitivity and Performance Monitoring During Reinforcement Learning: an ERP Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University of Electronic Science and Technology of China · Academic / Other
- Sex
- Male
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
The main aim of the study is to investigate whether intranasal oxytocin (24IU) influences reward sensitivity and performance monitoring during reinforcement learning.
Detailed description
A double-blind, within-subject, placebo-controlled pharmacological EEG design will be employed. A total of 35 healthy male subjects will be recruited which will receive either intranasal placebo or oxytocin (24IU) on two separate study days (order counter-balanced, washout period at least 2 weeks). 45 minutes after treatment subjects will undergo a probabilistic feedback reinforcement learning paradigm with concurrent EEG acquisition. During the paradigm subjects will learn the reward probabilities of two different visual stimuli from probabilistic feedback provided by social stimuli (positive, negative emoticon). The paradigm includes an initial acquisition phase and a subsequent test phase.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | intranasal oxytocin | 24 IU of oxytocin nasal spray will be applied to each subject. |
| DRUG | intranasal placebo | an identical amount of placebo nasal spray will be applied to each subject. |
Timeline
- Start date
- 2018-12-04
- Primary completion
- 2019-03-31
- Completion
- 2019-07-31
- First posted
- 2019-02-19
- Last updated
- 2019-02-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03846271. Inclusion in this directory is not an endorsement.